糖心vlog

[Skip to Navigation]
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
糖心vlog Home
JAMA Cardiology
Sign In
New Online Current Issue Past Issues
糖心vlog Statement on Potentially Offensive Content

October 2024 - April 2016

Decade

Year

Issue

May 2018, Vol 3, No. 5, Pages 361-445

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2018;3(5):361. doi:10.1001/jamacardio.2017.3361
Original Investigation

The Burden of Cardiovascular Diseases Among US States, 1990-2016

Global Burden of Cardiovascular Diseases Collaboration
Abstract Full Text
open access
JAMA Cardiol. 2018;3(5):375-389. doi:10.1001/jamacardio.2018.0385

This study using the Global Burden of Disease methodology quantifies and describes levels and trends of lost health due to cardiovascular disease within the United States from 1990 to 2016 as well as risk factors driving these changes.

Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial

Otavio Berwanger, MD, PhD; Jose C. Nicolau, MD, PhD; Antonio C. Carvalho, MD, PhD; et al.
Abstract Full Text
free access
JAMA Cardiol. 2018;3(5):391-399. doi:10.1001/jamacardio.2018.0612

This randomized clinical trial evaluates the short-term safety of ticagrelor when compared with clopidogrel in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy.

ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study

Steven E. Nissen, MD; Sreekumar G. Pillai, PhD; Stephen J. Nicholls, MBBS, PhD; et al.
Abstract Full Text
free access
JAMA Cardiol. 2018;3(5):401-408. doi:10.1001/jamacardio.2018.0569

This study explores whether the association between an SNP in the ADCY9 gene and a reduction in major adverse cardiovascular events could be replicated for another cholesteryl ester transfer protein inhibitor, evacetrapib, in patients with high-risk vascular disease.

Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch

Geoffrey H. Tison, MD, MPH; José M. Sanchez, MD; Brandon Ballinger, BS; et al.
Abstract Full Text
free access has audio
JAMA Cardiol. 2018;3(5):409-416. doi:10.1001/jamacardio.2018.0136

This study aims to develop and validate a deep neural network to detect atrial fibrillation using smartwatch data.

  • Podcast: Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch

Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation

Jawad H. Butt, MD; Ying Xian, MD, PhD; Eric D. Peterson, MD, MPH; et al.
Abstract Full Text
free access
JAMA Cardiol. 2018;3(5):417-424. doi:10.1001/jamacardio.2018.0405

This cohort study examines long-term risk of thromboembolism in patients with new-onset postoperative atrial fibrillation after first-time isolated coronary artery bypass graft surgery compared with patients with nonvalvular atrial fibrillation.

Brief Report

Trajectories of Blood Pressure Elevation Preceding Hypertension Onset: An Analysis of the Framingham Heart Study Original Cohort

Teemu J. Niiranen, MD; Mir Henglin, BA; Brian Claggett, PhD; et al.
Abstract Full Text
free access
JAMA Cardiol. 2018;3(5):427-431. doi:10.1001/jamacardio.2018.0250

This longitudinal cohort study aimed to identify a common threshold level above which blood pressure level rise tends to accelerate in progression toward hypertension.

Viewpoint

Mass Customization for Population Health

Kevin G. Volpp, MD, PhD; Harlan M. Krumholz, MD, SM; David A. Asch, MD, MBA
Abstract Full Text
JAMA Cardiol. 2018;3(5):363-364. doi:10.1001/jamacardio.2017.5353

This Viewpoint argues that, rather than inventing new medications and procedures, it is best to augment use of existing therapies by fine-tuning health care delivery through the use of data.

Editorial

Mass Customization, Ubiquitous Information, and Improvements to Health Outcomes in the United States

Robert M. Califf, MD
Abstract Full Text
JAMA Cardiol. 2018;3(5):365-366. doi:10.1001/jamacardio.2017.5354

Geographic Variation in Cardiovascular Disease Burden: Clues and Questions

Wayne D. Rosamond, PhD, MS
Abstract Full Text
JAMA Cardiol. 2018;3(5):366-368. doi:10.1001/jamacardio.2018.0387

A Perspective on Physiologic Assessment of Coronary Stenoses in Series: Methods, Myths, and Best Practices?

Morton J. Kern, MD, MSCAI, FAHA; Arnold H. Seto, MD, MPA, FSCAI
Abstract Full Text
JAMA Cardiol. 2018;3(5):368-370. doi:10.1001/jamacardio.2018.0239

Moving From Big Data to Deep Learning鈥擳he Case of Atrial Fibrillation

Mintu P. Turakhia, MD, MAS
Abstract Full Text
JAMA Cardiol. 2018;3(5):371-372. doi:10.1001/jamacardio.2018.0207

JAMA Cardiology鈥擳he Year in Review, 2017

Robert O. Bonow, MD, MS
Abstract Full Text
free access
JAMA Cardiol. 2018;3(5):373-374. doi:10.1001/jamacardio.2017.4979
Invited Commentary

Late Stroke After Coronary Artery Bypass Grafting

Jeff S. Healey, MD, MSc, FRCPC; William F. McIntyre, MD; Richard P. Whitlock, MD, PhD
Abstract Full Text
JAMA Cardiol. 2018;3(5):425-426. doi:10.1001/jamacardio.2018.0534
Review

Physiology-Guided Management of Serial Coronary Artery Disease: A Review

Bhavik N. Modi, MA, MBBS; Kalpa De Silva, MBBS, PhD; Ronak Rajani, MBBS, PhD; et al.
Abstract Full Text
JAMA Cardiol. 2018;3(5):432-438. doi:10.1001/jamacardio.2018.0236

This review addresses the application of physiological techniques to serial coronary disease, highlighting challenges and potential solutions.

JAMA Cardiology Clinical Challenge

Hip Fracture and Palpitations in a 92-Year-Old Woman With Bronchiectasis

Paurush Ambesh, MD; Gerald Hollander, MD; Jacob Shani, MD
Abstract Full Text
JAMA Cardiol. 2018;3(5):439-440. doi:10.1001/jamacardio.2017.3512

A 92-year-old woman with a history of long-term bronchiectasis and atrial flutter presented after a fall with severe pain over the left hip and occasional palpitations. The 12-lead electrocardiogram showed marked right axis deviation with poor R wave progression across the precordial leads V1-V6. What would you do next?

Comment & Response

Complete vs Incomplete Revascularization During Percutaneous Coronary Intervention and Improved Survival鈥擳he Key Is Immortality

Eric A. Secemsky, MD, MSc; Robert W. Yeh, MD, MSc
Abstract Full Text
JAMA Cardiol. 2018;3(5):443-444. doi:10.1001/jamacardio.2018.0078

Importance of Objectively Comparing Local VA and Non-VA Care and Outcomes: Serving Veterans Well

William B. Weeks, MD, PhD, MBA
Abstract Full Text
JAMA Cardiol. 2018;3(5):443. doi:10.1001/jamacardio.2018.0338

Complete vs Incomplete Revascularization During Percutaneous Coronary Intervention and Improved Survival鈥擳he Key Is Immortality鈥擱eply

Edward L. Hannan, PhD, MS; Ye Zhong, MD, MS
Abstract Full Text
JAMA Cardiol. 2018;3(5):444-445. doi:10.1001/jamacardio.2018.0271
Editor's Note

Maturing Methods for Cardiovascular Disease and Stroke Surveillance in the United States

Mark D. Huffman, MD, MPH
Abstract Full Text
JAMA Cardiol. 2018;3(5):390. doi:10.1001/jamacardio.2018.0812

The TREAT Trial鈥擬oving ST-Elevation Myocardial Infarction Care Forward, With More to Do

Clyde W. Yancy, MD, MSc; Robert A. Harrington, MD
Abstract Full Text
JAMA Cardiol. 2018;3(5):399-400. doi:10.1001/jamacardio.2018.0644

Pharmacogenetics and the Promise of Personalized Medicine

Marc S. Sabatine, MD, MPH
Abstract Full Text
JAMA Cardiol. 2018;3(5):408. doi:10.1001/jamacardio.2018.0586
Correction

Errors in Figure 3 and Affiliations

Abstract Full Text
free access
JAMA Cardiol. 2018;3(5):445. doi:10.1001/jamacardio.2018.0643

Error in Author Byline

Abstract Full Text
free access
JAMA Cardiol. 2018;3(5):445. doi:10.1001/jamacardio.2018.1067
Peer Reviewers List

JAMA Cardiology Peer Reviewers in 2017

Abstract Full Text
free access online only
JAMA Cardiol. 2018;3(5):e174980. doi:10.1001/jamacardio.2017.4980
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2018;3(5):362. doi:10.1001/jamacardio.2017.3362
Most Viewed(30 Days) RSS link
Most Cited(3 Years) RSS Link
View more
View more
×
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)鈥�
Sign in or create a free account
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)鈥�
Sign in or create a free account
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
  • Register for email alerts with links to free full-text articles
  • Access PDFs of free articles
  • Manage your interests
  • Save searches and receive search alerts
Privacy Policy